| In This Issue |
|
l |
Tumors Employ Defense System
to Escape Attack by Antitumor Immune Cells |
|
l |
New Imaging Agent Has Potential to Diagnose and Track Prostate Cancer |
|
l |
Newly Patented Method to Grow Unculturable Bacteria May Lead to Drug Discovery |
|
l |
Licensing Deal for Disease-detection Technology |
|
l |
Of Note |
|
l |
Upcoming Campus Lectures | |
|
|
|
| |
|
|
Tumors Employ Defense System to Escape Attack by Antitumor Immune Cells In a new study, Michail Sitkovsky, Director of the New England Inflammation and Tissue Protection Institute and his colleagues at NIH show that cancerous tissues in mice employ an adenosine-based defense system to combat antitumor T cells. The study, reported in Proceedings of the National Academy of Sciences, is expected to aid the work of cancer immunologists in improving antitumor T cells.
|
|
|
|
New Imaging Agent Has Potential to Diagnose and Track Prostate Cancer
Research by Chemistry and Chemical Biology Chair
Graham Jones has led to the discovery of a new image contrast agent selectively activated by prostate specific antigen. Several early alert journals featured the research.
>> Read an article. |
|
|
|
Newly Patented Method to Grow Unculturable Bacteria May Lead to Drug Discovery
Developed after years of research by Kim Lewis and
Slava Epstein, Professor and Associate Professor of Biology, the breakthrough method, patented in 2006, allows the growth of previously unculturable bacteria. This invention, first described in a Science publication in 2002, is licensed to NovoBiotic Pharmaceuticals, a company that uses previously unculturable bacteria as a source for drug discovery.
>> Read an article.
|
|
|
|
Licensing Deal for Disease-detection Technology
Novel proteomics technology developed by Barnett Institute Director Barry Karger and Bradstreet Chair in Analytical Chemistry William Hancock has been licensed to Biosystems International. The technology will be used to detect low concentrations of the biomarkers that indicate illness.
>> Read an article. |
|
|
|
Of Note
Michail Sitkovsky, Director of the New England Inflammation and Tissue Protection Institute, was honored with the Nicolaus Copernicus Award at the 8th International Conference on Adenosine in Ferrara, Italy this past May.
Alexandros Makriyannis, Director of the Center for Drug Discovery, received the International Cannabinoid Research Society?s Mechoulam Award in Budapest in June.
Ana Cristina Robles is the first student in the Biotechnology MS Program to receive a Draper Laboratory Fellowship. She will be performing research at Draper Laboratory to develop a breath test to identify tuberculosis biomarkers.
Undergraduate Nursing student Kristen Daley has been awarded a Steamboat Foundation Scholarship. She will be performing quality improvement research in pediatric oncology and promoting excellence in patient care at the Dana Farber Cancer Institute. |
|
|
|
Upcoming Campus Lectures
Barry A. Berkowitz, Pharmacy '64, President and CEO of Cetek Corporation will be the featured speaker at the annual Biotechnology Entrepreneur Lecture Series on September 14. Dr. Berkowitz will present "Between the Bench and Wall Street: the Life Cycle of Scientific Ideas".
Mark S. Boguski, VP and Global Head of Genome and Proteome Sciences at Novartis Institutes for Biomedical Research will present "The End of the Interlude: Some Reflections on Bioinformatics, Proteomics, Systems Biology and Experimental Medicine" at the College of Computer
and Information Science Distinguished Speaker Series on September 28.
For more information, see Upcoming Events. |
|
|
|
The Biotechnology Initiative promotes state-of-the-art interdisciplinary research and innovative education at Northeastern with emphasis on close collaboration with industry and medical communities. Biotechnology Initiative
Northeastern University | |
e-mail: c.bainton@neu.edu
phone: 617-373-2627
web: www.biotech.neu.edu | |
